Dr Agarwal’s Healthcare allotment today: How to check allotment status online on BSE, NSE, KFin Technologies

Dr Agarwal’s Healthcare, recently concluded its IPO. The company’s public issue, which opened for bidding on January 29, closed on January 31, with a price band set between the range of Rs 382 to Rs 402 per share.

The allotment status is likely to be finalised on today, February 3. Those who get allotted shares will see them credited to their demat accounts before the listing date. Dr Agarwals Healthcare shares are set to list on both the BSE and NSE on February 5.

How to Check Dr Agarwals Healthcare IPO Allotment Status

Investors who applied for shares in Dr Agarwals Healthcare IPO can check the allotment status online through multiple platforms such as BSE, NSE or the registrar, KFin Technologies. Here’s the step by step guide to check the status:

– Via BSE

  • Go to BSE’s IPO allotment page: BSE IPO Status
  • Select ‘Equity’ as the issue type
  • Choose ‘Dr Agarwal’s Healthcare Ltd’ from the IPO names list
  • Enter your PAN Number or Application Number
  • Click on ‘Submit’ to check if you have been allotted shares

Also ReadUpcoming IPOs this week: 5 new SME issues and 2 listings to watch – Via NSE

  • Visit NSE’s bid verification portal: NSE IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’
  • Enter your Application Number and PAN Number
  • Click on ‘Submit’ to view the status

– Via  KFin Technologies

  • Visit the IPO allotment status page: KFin Technologies IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’ from the IPO dropdown list
  • Enter your PAN, Application Number, DP ID, or Account Number
  • Fill in the required details for verification
  • Click on ‘Submit’ to check your allotment status

Dr Agarwal IPO: Subscription and GMP Trends

Dr Agarwals Healthcare IPO received a subscription of 1.49 times by the end of the bidding period. Breaking it down, QIBs portion saw a subscription rate of 4.41 times, NII portion was booked 0.39 times and the retail portion received a subscription rate of 0.42 times.

GMP: As per the latest GMP trends, the stock is trading at a Rs 1.5 premium, hinting at a listing price of around Rs 403.5 per share.

 » Read More

Related Articles

Nasdaq jumps 1% as tech stocks surge, S&P 500 ends higher as cool inflation data calms tariff jitters

U.S. stocks advanced on Wednesday as cooler-than-expected inflation data helped stanch a sharp selloff, while the escalation of U.S. President Donald Trump’s chaotic, multi-front tariff war kept gains in check. The S&P 500 and the Nasdaq closed in positive territory, the latter enjoying a muscular boost from tech and tech-adjacent momentum stocks. The blue-chip Dow

EXPLAINER | Why an MF-insurance combo product may not be a good idea

The markets regulator recently said it plans to release a consultation paper on a new product that combines mutual fund schemes with term insurance. Given the underwriting concerns & implementation challenges, fund houses may not be too enthused, explains Ananya Grover Are there any bundled products in the market? There are already similar bundled products

Maximising output the ONGC way

The traditional exploration approach in oil and gas sector is expensive, risky, and prone to mistakes, as it heavily relies on human fieldwork. Even drilling dry holes hit oil and gas companies where it hurts – their wallets. The investment poured into geological assessment, drilling and testing goes up in smoke when the well doesn’t

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Nasdaq jumps 1% as tech stocks surge, S&P 500 ends higher as cool inflation data calms tariff jitters

U.S. stocks advanced on Wednesday as cooler-than-expected inflation data helped stanch a sharp selloff, while the escalation of U.S. President Donald Trump’s chaotic, multi-front tariff war kept gains in check. The S&P 500 and the Nasdaq closed in positive territory, the latter enjoying a muscular boost from tech and tech-adjacent momentum stocks. The blue-chip Dow

EXPLAINER | Why an MF-insurance combo product may not be a good idea

The markets regulator recently said it plans to release a consultation paper on a new product that combines mutual fund schemes with term insurance. Given the underwriting concerns & implementation challenges, fund houses may not be too enthused, explains Ananya Grover Are there any bundled products in the market? There are already similar bundled products

Maximising output the ONGC way

The traditional exploration approach in oil and gas sector is expensive, risky, and prone to mistakes, as it heavily relies on human fieldwork. Even drilling dry holes hit oil and gas companies where it hurts – their wallets. The investment poured into geological assessment, drilling and testing goes up in smoke when the well doesn’t

Infosys is helping clients optimise AI investments

Enterprise AI is driving business transformation, with over 50% of AI use cases delivering impact, according to Infosys. Success is highest in professional services and tech, while financial services face regulatory hurdles. Satish H C, EVP, chief delivery officer, Infosys, tells Padmini Dhruvaraj, that the company is investing in small language models, Agentic AI, and

Blackstone aims to double India exposure: CEO

Global private equity giant Blackstone will double its exposure in India over the next few years to $100 billion, co-founder, chairman and CEO Stephen A Schwarzman said on Wednesday. “India has been a great market for us, giving us best returns globally. We are not rigid about the (allocated) investments in India,” Schwarzman said during